Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT00663936

Public ClinicalTrials.gov record NCT00663936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a Multi-center, Randomized, Double Blind, Placebo-controlled Study to Investigate the Efficacy and Safety of T-817MAa in Patients With Mild to Moderate Alzheimer's Disease

Study identification

NCT ID
NCT00663936
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
FUJIFILM Toyama Chemical Co., Ltd.
Industry
Enrollment
373 participants

Conditions and interventions

Interventions

  • T-817MA Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2008
Primary completion
Apr 30, 2011
Completion
May 31, 2011
Last update posted
Nov 4, 2013

2008 – 2011

United States locations

U.S. sites
33
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Banner Alzheimer's Institute Phoenix Arizona 85006
Northwest NeuroSpecialists Tucson Arizona 85741
Collaborative Neuroscience Network, Inc. Garden Grove California 92845
Southwest Institute for Clinical Research, Inc. Rancho Mirage California 92270
Pacific Research Network, Inc. San Diego California 92103
San Francisco Clinical Research Center San Francisco California 94109
Radiant Research Denver Colorado 80239
Geriatric and Adult Psychiatry, LCC Hamden Connecticut 06518
Research Center for Clinical Studies, Inc. Norwalk Connecticut 06851
NeuroPsychiatric Center of the Palm Beaches Boynton Beach Florida 33426
Galiz Research Miami Springs Florida 33166
Anchor Research Center Naples Florida 34102
Renstar Medical Research Ocala Florida 34471
Axiom Clinical Research of Florida Tampa Florida 33609
Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute Tampa Florida 33613
Premiere Research Institute West Palm Beach Florida 33407
Columbus Research & Wellness Institute Columbus Georgia 31907
Agewell Indianapolis Indiana 46260
Cleveland Clinic - Lou Ruvo Center for Brain Health Las Vegas Nevada 89106
Comprehensive Clinical Research Berlin New Jersey 08009
Memory Enhancement Center of America Toms River New Jersey 08755
Brooklyn Medical Institute Brooklyn New York 11214
SPRI Clinical Trials Brooklyn New York 11235
Alzheimer's Disease Center, U. of Rochester Medical Center Rochester New York 14620
Richmond Behavioral Associates Staten Island New York 10312
The Alzheimer's Memory Center Charlotte North Carolina 28211
Duke University Medical Center Durham North Carolina 27705
Raleigh Neurology Associates Raleigh North Carolina 27607
Clinical Trials of America, Inc. Winston-Salem North Carolina 27103
The Clinical Trials Center Jenkintown Pennsylvania 19046
CRI Worldwide, LLC Philadelphia Pennsylvania 19139
Innovative Clinical Trials San Antonio Texas 78229
IPC Research Waukesha Wisconsin 53188

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00663936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2013 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00663936 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →